Bliss GVS Pharma profit increases 27.53% in (Q3) FY 2020-21

Source

Team Infinities:

Bliss GVS Pharma Limited NSE Symbol:BLISSGVS, BSE Security Code:506197 has declared its 3rd(third) quarter unaudited consolidated financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.

Revenue Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
168.18 154.28 153.37 459.05 590.03
Calculated Revenue of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
13.90 9.01%(Revenue Increase) 14.81 9.66%(Revenue Increase) 130.98 22.20%(Revenue Decrease)

Revenue: Bliss GVS Pharma Limited's financial report shows that the company's revenue increased by 9.01% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue increase of Rs.13.90 crores, as the company posted revenue of Rs.168.18 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.154.28 crores.
The result also shows that the company's revenue increased by 9.66% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.14.81 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.153.37 crores.
The company also reported that its revenue decreased by 22.20% in 9 months end(April, 2020 - December, 2020) for revenue decrease of Rs.130.98 crores, since the company reported revenue of Rs.459.05 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.590.03 crores.

Gross Margin(%) Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
51.65 35.00 39.40 41.68 34.84
Calculated Gross Margin(%) of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
16.65 47.57%(GM Increase) 12.26 31.11%(GM Increase) 6.84 19.64%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 47.57% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 16.65% GM increase, as the company reported 51.65% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 35.00% GM.
The result also indicates, the company's GM increased by 31.11% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 12.26% GM increase; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 39.40% GM.
The company also reported that its GM increased by 19.64% in 9 months end(April, 2020 - December, 2020) for 6.84% GM increase, since the company reported 41.68% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 34.84% GM.

EBITDA Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
42.39 34.75 38.46 103.66 127.90
Calculated EBITDA of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
7.64 21.99%(EBITDA Increase) 3.93 10.22%(EBITDA Increase) 24.24 18.95%(EBITDA Decrease)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 21.99% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.7.64 crores, as the company posted EBITDA of Rs.42.39 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.34.75 crores.
The result also shows that the company's EBITDA increased by 10.22% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.3.93 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.38.46 crores.
The company also reported that its EBITDA decreased by 18.95% in 9 months end(April, 2020 - December, 2020) for EBITDA decrease of Rs.24.24 crores, since the company reported EBITDA of Rs.103.66 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EBITDA of Rs.127.90 crores.

Profit and Loss Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
27.56(Profit ) 21.61(Profit ) 25.45(Profit ) 65.82(Profit ) 89.68(Profit )
Calculated Profit and Loss of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
5.95 27.53%(Profit Increase) 2.11 8.29%(Profit Increase) 23.86 26.61%(Profit Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 27.53% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit increase of Rs.5.95 crores, as the company posted profit of Rs.27.56 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.21.61 crores.
The result also shows that the company's profit increased by 8.29% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.2.11 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.25.45 crores.
The company also reported that its profit decreased by 26.61% in 9 months end(April, 2020 - December, 2020) for profit decrease of Rs.23.86 crores, since the company reported profit of Rs.65.82 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted profit of Rs.89.68 crores.

EPS Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 9 Months Ended (April, 2020 - December, 2020) Corresponding 9 Months Ended (April, 2019 - December, 2019)
2.48 1.99 2.30 6.03 8.58
Calculated EPS of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019)
Change Change % Change Change % Change Change %
0.49 24.62%(EPS Increase) 0.18 7.83%(EPS Increase) 2.55 29.72%(EPS Decrease)

EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 24.62% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.49, as the company posted EPS of Rs.2.48; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.1.99.
The result also shows that the company's EPS increased by 7.83% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.18; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.2.30.
The company also reported that its EPS decreased by 29.72% in 9 months end(April, 2020 - December, 2020) for EPS decrease of Rs.2.55, since the company reported EPS of Rs.6.03; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EPS of Rs.8.58.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.